BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $12,912,000 | +14.2% | 9,800,000 | -7.5% | 0.00% | 0.0% |
| Q1 2020 | $11,304,000 | -15.5% | 10,600,000 | -13.8% | 0.00% | 0.0% |
| Q4 2019 | $13,383,000 | +7.4% | 12,300,000 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $12,462,000 | -3.7% | 12,000,000 | +4.3% | 0.00% | 0.0% |
| Q2 2019 | $12,940,000 | +13.8% | 11,500,000 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $11,373,000 | -16.7% | 9,950,000 | -18.8% | 0.00% | 0.0% |
| Q4 2018 | $13,645,000 | -14.6% | 12,250,000 | -7.5% | 0.00% | 0.0% |
| Q3 2018 | $15,975,000 | +3.3% | 13,250,000 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $15,466,000 | +20.4% | 13,050,000 | +13.0% | 0.00% | 0.0% |
| Q1 2018 | $12,850,000 | -6.4% | 11,550,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,730,000 | -2.6% | 11,550,000 | -0.9% | 0.00% | 0.0% |
| Q3 2017 | $14,099,000 | – | 11,650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 5,590,000 | $6,433,196,000 | 1.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,450,000 | $14,458,000 | 1.24% |
| LINDEN ADVISORS LP | 20,760,000 | $24,046,000 | 1.05% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,250,000 | 0.72% |
| Man Investments (CH) AG | 900,000 | $1,043,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,600,000 | $7,631,000 | 0.53% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,035,000 | $32,497,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 2,067,000 | $2,389,000 | 0.23% |
| Calamos Advisors LLC | 23,382,000 | $27,088,000 | 0.19% |
| LOOMIS SAYLES & CO L P | 591,575 | $46,025,000 | 0.12% |